Conducting multi-country real-world observational studies and healthcare database analyses for over 20 years, our services are grounded in the extensive heritage afforded by Adelphi’s proprietary Disease Specific Programmes™ and supported by the subsequent expansion of our real-world evidence services to meet pharmaceutical client needs.
We provide a unique range of real-world insights involving physicians, patients, caregivers and payers; with insights achieved through our market-leading Disease Specific Programmes™, tailored non-interventional studies, international secondary database analyses and expert market access strategy.
Adelphi Real World is a dedicated team of more than 100 professionals; we provide support and guidance for our clients across all areas of real-world evidence implementation.
Our scope of work and experience covers the complete lifecycle of a compound. Our global coverage ensures our evidence can shape all levels of insight from multi-country strategy through to domestic, tactical implementation.